Inhibikase Therapeutics Inc. (IKT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inhibikase Therapeutics I...

    NASDAQ: IKT · Real-Time Price · USD
    1.67
    -0.04 (-2.34%)
    At close: Sep 05, 2025, 3:59 PM
    1.67
    0.00%
    After-hours: Sep 05, 2025, 04:41 PM EDT

    Inhibikase Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 56.49M 9.17M 7.19M 40.75M
    Short-Term Investments
    		 41.05M 4.09M 15.86M n/a
    Long-Term Investments
    		 n/a n/a -15.85M n/a
    Other Long-Term Assets
    		 47.1K n/a 15.85M n/a
    Receivables
    		 n/a n/a 39.88K 110.14K
    Inventory
    		 n/a n/a 1.12M 107K
    Other Current Assets
    		 826.47K 739.18K 163.45K 1.5M
    Total Current Assets
    		 98.45M 14.21M 24.37M 42.47M
    Property-Plant & Equipment
    		 101.44K 295.6K 565.17K n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 148.54K 295.6K 565.17K n/a
    Total Assets
    		 98.6M 14.51M 24.94M 42.47M
    Account Payables
    		 943.02K 646.77K 1.15M 1.09M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 110.52K 381.78K 145.84K 248.91K
    Other Current Liabilities
    		 -110.52K 635.45K 1.79M n/a
    Total Current Liabilities
    		 3.73M 3.44M 3.7M 4.05M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a 90.12K 205.45K 2.72M
    Total Liabilities
    		 3.73M 3.53M 3.9M 4.05M
    Total Debt
    		 110.52K 622K 351.29K 248.91K
    Common Stock
    		 69.36K 6.19K 25.23K 25.16K
    Retained Earnings
    		 -94.42M -66.9M -47.87M -29.82M
    Comprehensive Income
    		 -37.25K 877.00 104.72K -0.00
    Shareholders Equity
    		 94.87M 10.98M 21.04M 38.42M
    Total Investments
    		 41.05M 4.09M 15.86K n/a

    Add to Watchlist